CN112914799A - Anti-infection absorbable nursing urethral stent suitable for hypospadias operation - Google Patents
Anti-infection absorbable nursing urethral stent suitable for hypospadias operation Download PDFInfo
- Publication number
- CN112914799A CN112914799A CN202110081373.6A CN202110081373A CN112914799A CN 112914799 A CN112914799 A CN 112914799A CN 202110081373 A CN202110081373 A CN 202110081373A CN 112914799 A CN112914799 A CN 112914799A
- Authority
- CN
- China
- Prior art keywords
- degradable
- tube
- fixedly arranged
- infection
- liquid medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
Abstract
The invention discloses an anti-infection absorbable nursing urethral stent applicable to a hypospadias operation, which comprises a tube body, a first balloon, a second balloon, a degradable stent ring, an inner spacer tube, a first anti-infection liquid medicine sleeve, an A degradable spacer, a B degradable spacer, a second anti-infection liquid medicine sleeve, a C degradable spacer and a D degradable spacer, wherein the first balloon and the second balloon are matched to support a bladder and a urethra to effectively prevent urethral stricture, and the degradable stent ring solves the problem that the degradable stent ring is not a degradable material and therefore brings pain to a patient when the tube body is detached in the prior art, and finally, the anti-infection and anti-inflammation liquid medicines are dissolved in sequence through an anti-bacterial and anti-inflammation structure, so that the anti-bacterial and anti-inflammation liquid medicines can permeate into the urethra in batches to realize batch disinfection, meanwhile, the antibacterial and anti-inflammatory time is prolonged, and the problem that external germs invade the urethra of a patient in the catheterization process is prevented.
Description
Technical Field
The invention relates to the technical field of medical instruments, in particular to an anti-infection absorbable nursing urethral stent suitable for use after a hypospadias operation.
Background
Hypospadias is one of the most common congenital urogenital malformations in children, with a morbidity rate of about 0.91-1.86%. The infant mainly shows abnormal urethral orifice, abnormal urine flow and downward bending of penis, which results in abnormal urination of the infant and affects the sexual function and fertility of the adult. Surgery is a more effective method for treating hypospadias, but due to the specific anatomical structure and physiological limitations of the penis, the incidence of postoperative complications, such as urinary leakage, urethral stricture, urethral diverticulum, urethral rupture, etc., is high. In the early period of wound recovery after the hypospadias (7-10 days after operation), in order to guide urine out of the bladder to prevent urine retention and reduce the infection rate after operation due to stimulation of the urine to the wound, a bracket is placed on the urethra. In the later period of wound recovery after the hypospadias operation, the probability of wound infection is reduced, and the urinary tract infection risk can be increased by continuously keeping the urinary catheter. In addition, as the urethra wound is not completely healed in the later period of the wound recovery after the hypospadias, the urethra catheter is completely pulled out, so that the reconstructed urethra loses support, and urethral stricture is easy to occur.
According to the above, the existing post-urethral reconstruction stent is formed by cutting the same full-length urethral stent tube, the full-length urethral stent tube is used in the early period of postoperative wound recovery, and the head end of the full-length urethral stent tube needs to be withdrawn from the bladder in the later period of postoperative wound recovery, cut short and fixed on the glans penis again. The glans and the urinary nerve endings are abundant, so the process of dismantling and then fixing again brings certain pain to the patient, and in addition, the generation of postoperative urethral stricture, infection and other complications of the patient with the hypospadias is also increased. Therefore, in view of the above disadvantages, there is a need for an anti-infective absorbable nursing urethral stent suitable for use after a hypospadias operation.
Disclosure of Invention
The technical problem to be solved by the invention is as follows: provides an anti-infection absorbable nursing urethral stent applicable to after a hypospadias operation, which solves the problems brought forward by the background technology.
In order to solve the technical problems, the technical scheme of the invention is as follows: an anti-infection absorbable nursing urethral stent applicable to after a hypospadias operation comprises a tube body, a first balloon, a second balloon, a degradable stent ring, an inner spacer tube, a first anti-infection liquid medicine sleeve, an A degradable spacer body, a B degradable spacer body, a second anti-infection liquid medicine sleeve, a C degradable spacer body and a D degradable spacer body, wherein the first balloon is fixedly arranged at the top port of the tube body, the first balloon is connected with the tube body by hot melting, the second balloon is fixedly arranged at the upper end of the outer wall of the tube body and is connected with the tube body by hot melting, the degradable support frame is fixedly arranged at the outer wall of the second balloon, the degradable support frame and the second balloon are connected by medical grade adhesive, the inner spacer tube is arranged at the bottom of the tube body, the inner spacer tube is connected with the tube body by hot melting, and the inner spacer tube is connected with the first balloon by hot melting, the first anti-infection liquid medicine sleeve is fixedly arranged at the inner upper end of the pipe body, the first anti-infection liquid medicine sleeve is connected with the pipe body in a hot melting mode, the first anti-infection liquid medicine sleeve is connected with the inner partition pipe in a hot melting mode, the A degradable partition body is fixedly arranged at the inner upper end of the first anti-infection liquid medicine sleeve, the A degradable partition body is connected with the first anti-infection liquid medicine sleeve in an adhesive mode, the A degradable partition body is connected with the inner partition pipe in a medical adhesive mode, the B degradable partition body is fixedly arranged at the inner lower end of the first anti-infection liquid medicine sleeve, the B degradable partition body is connected with the first anti-infection liquid medicine sleeve in a medical adhesive mode, the B degradable partition body is connected with the inner partition pipe in a medical adhesive mode, the second anti-infection liquid medicine sleeve is fixedly arranged at the inner lower end of the pipe body, and the second anti-infection liquid medicine sleeve is connected with the pipe, the second anti-infection liquid medicine sleeve is connected with the inner partition pipe in a hot melting mode, the C degradable partition body is fixedly arranged at the upper end of the inner portion of the second anti-infection liquid medicine sleeve and connected with the second anti-infection liquid medicine sleeve through a medical adhesive, the C degradable partition body is connected with the inner partition pipe through the medical adhesive, the D degradable partition body is fixedly arranged at the lower end of the inner portion of the second anti-infection liquid medicine sleeve and connected with the second anti-infection liquid medicine sleeve through the medical adhesive, and the D degradable partition body is connected with the inner partition pipe through the medical adhesive.
Furthermore, the front side and the rear side of the inner upper end of the pipe body and the inner partition are also provided with flow guide holes, and the flow guide holes are through holes.
Further, first sacculus bottom middle-end still set firmly first regulation trachea, first regulation trachea and first sacculus adopt hot melt to be connected, first regulation trachea bottom still set firmly first governing valve, first governing valve and first regulation trachea adopt hot melt to be connected, first governing valve bottom still set firmly first connection port, first connection port and first governing valve adopt hot melt to be connected.
Further, second sacculus inner wall still run through and have the second to adjust the trachea, second adjust trachea and second sacculus adopt hot melt to be connected, just the second adjust trachea adopt hot melt to be connected with body and interior spacer pipe respectively, the second adjust trachea still set firmly the second governing valve, second governing valve and second adjust trachea adopt hot melt to be connected, second governing valve bottom still set firmly the second connection port, second connection port and second governing valve adopt hot melt to be connected.
Further, degradable support ring outer wall from last to still having set firmly the skid proof convex block of a plurality of quantity down, protection convex block and degradable support ring integrated into one piece.
Further, the inside lower extreme of first anti-infective liquid medicine cover still run through and have first notes liquid pipe, first notes liquid pipe and first anti-infective liquid medicine cover adopt the hot melt to be connected, just first notes liquid pipe adopt medical grade adhesive to be connected with A degradable spacer and B degradable spacer respectively, first notes liquid socle portion still set firmly first notes liquid interface, first notes liquid interface and first notes liquid pipe adopt the hot melt to be connected.
Further, the second prevent infecting the inside lower extreme of liquid medicine cover and still run through the second and annotate the liquid pipe, the second annotate liquid pipe and the second prevent infecting the liquid medicine cover and adopt the hot melt to be connected, just the second annotate the liquid pipe respectively with C degradable separate body and D degradable separate body adopt medical grade adhesive to be connected, the second annotate liquid socle portion still set firmly the second and annotate the liquid interface, the second annotate liquid interface and second and annotate liquid pipe and adopt the hot melt to be connected.
Furthermore, the degradable stent ring, the degradable spacer A, the degradable spacer B, the degradable spacer C, the degradable spacer D and the anti-skid bump material are all biological materials which can be dissolved by ascorbic acid, and the biological materials which can be dissolved by the ascorbic acid are chitosan or similar biological materials.
Compared with the prior art, the anti-infection absorbable nursing urethral stent applicable to after the hypospadias operation has the following advantages:
1. at first by first sacculus, second sacculus and degradable support ring interact each other, can not only support the bladder, also can expand and support the urethra in addition, effectively prevented the narrow problem of hypospadias postoperative.
2. Secondly, because the degradable support ring is made of degradable materials, the problem that great pain is brought to a patient due to the fact that the degradable support ring is not made of degradable materials when the pipe body is detached in the traditional technology is solved.
3. Finally, the dissolution is ordered by the matching action of the degradable material and the antibacterial and anti-inflammatory structure, so that the antibacterial and anti-inflammatory liquid medicine can conveniently permeate into the urethra of the patient in batches, batch disinfection is realized, the antibacterial and anti-inflammatory time is prolonged, and the problem that external germs invade the urethra of the patient in the tube placing process is effectively prevented.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, and it is obvious that the drawings in the following description are some embodiments of the present invention, and other drawings can be obtained by those skilled in the art without creative efforts.
FIG. 1 is a front view of an anti-infective absorbable nursing urethral stent suitable for use after a hypospadias procedure;
FIG. 2 is a perspective view of an anti-infective absorbable nursing urethral stent suitable for use after a hypospadias procedure 1;
FIG. 3 is a cross-sectional, isometric view of an anti-infective, absorbable and nursing urethral stent suitable for use after a hypospadias procedure;
FIG. 4 is an enlarged perspective view of a first balloon site;
FIG. 5 is an enlarged perspective view of the second fluid injection port;
FIG. 6 is a cross-sectional enlarged perspective view of a degradable stent ring site;
FIG. 7 is an enlarged cross-sectional perspective view of a second regulator valve location;
fig. 8 is a perspective view of an anti-infective absorbable nursing urethral stent suitable for use after a hypospadias procedure 2.
The anti-infection medical liquid injection device comprises a tube body 1, a first balloon 2, a second balloon 3, a degradable support ring 4, an inner partition tube 5, a first anti-infection medical liquid sleeve 6, an A degradable partition body 7, a B degradable partition body 8, a second anti-infection medical liquid sleeve 9, a C degradable partition body 10, a D degradable partition body 11, a flow guide hole 101, a first adjusting air tube 201, a first adjusting valve 202, a first connecting port 203, a second adjusting air tube 301, a second adjusting valve 302, a second connecting port 303, an anti-skidding lug 401, a first liquid injection tube 601, a first liquid injection interface 602, a second liquid injection tube 901 and a second liquid injection interface 902.
The following detailed description will be further described in conjunction with the above-identified drawings.
Detailed Description
In the following description, numerous specific details are set forth in order to provide a thorough understanding of the concepts underlying the described embodiments, however, it will be apparent to one skilled in the art that the described embodiments may be practiced without some or all of these specific details, and in other cases well-known process steps have not been described in detail.
In the description of the present invention, it is to be understood that the terms "upper", "lower", "front", "rear", "left", "right", "top", "bottom", "inner", "outer", and the like, indicate orientations or positional relationships based on the orientations or positional relationships shown in the drawings, are merely for convenience in describing the invention and simplifying the description, and do not indicate or imply that the device or element referred to must have a particular orientation, be constructed and operated in a particular orientation, and thus, should not be construed as limiting the invention.
As shown in fig. 1, fig. 2, fig. 3, fig. 4, fig. 5, fig. 6, fig. 7 and fig. 8, an anti-infection absorbable nursing urethral stent suitable for use after a hypospadias operation comprises a tube body 1, a first balloon 2, a second balloon 3, a degradable stent ring 4, an inner septum 5, a first anti-infection liquid medicine sleeve 6, an a degradable septum 7, a B degradable septum 8, a second anti-infection liquid medicine sleeve 9, a C degradable septum 10 and a D degradable septum 11, wherein the first balloon 2 is fixedly arranged at the top port of the tube body 1, the first balloon 2 is connected with the tube body 1 by hot melting, the second balloon 3 is fixedly arranged at the upper end of the outer wall of the tube body 1, the second balloon 3 is connected with the tube body 1 by hot melting, the degradable stent 4 is fixedly arranged at the outer wall of the second balloon 3, the degradable stent 4 is connected with the second balloon 3 by medical grade adhesive, the inner partition pipe 5 is placed at the bottom of the pipe body 1, the inner partition pipe 5 is connected with the pipe body 1 in a hot melting mode, the inner partition pipe 5 is connected with the first balloon 2 in a hot melting mode, the first anti-infection liquid medicine sleeve 6 is fixedly arranged at the upper end inside the pipe body 1, the first anti-infection liquid medicine sleeve 6 is connected with the pipe body 1 in a hot melting mode, the first anti-infection liquid medicine sleeve 6 is connected with the inner partition pipe 5 in a hot melting mode, the degradable partition body A7 is fixedly arranged at the upper end inside the first anti-infection liquid medicine sleeve 6, the degradable partition body A7 is connected with the first anti-infection liquid medicine sleeve 6 in an adhesive mode, the degradable partition body A7 is connected with the inner partition pipe 5 in a medical adhesive mode, the degradable partition body B8 is fixedly arranged at the lower end inside the anti-infection liquid medicine sleeve 6, the degradable partition body B8 is connected with the first anti-infection liquid medicine sleeve 6 in a medical adhesive mode, the degradable partition body 8 and the inner partition pipe 5 are connected by medical adhesive, the second anti-infection liquid medicine sleeve 9 is fixedly arranged at the lower end of the inner part of the pipe body 1, the second anti-infection liquid medicine sleeve 9 is connected with the pipe body 1 by hot melting, the second anti-infection liquid medicine sleeve 9 is connected with the inner partition pipe 5 by hot melting, the C degradable partition 10 is fixedly arranged at the upper end inside the second anti-infection liquid medicine sleeve 9, the degradable partition body C10 is connected with the second anti-infection liquid medicine sleeve 9 by medical adhesive, the degradable partition body (10) of the C is connected with the inner partition pipe (5) by medical adhesive, the degradable partition body (11) of the D is fixedly arranged at the lower end inside the second anti-infection liquid medicine sleeve (9), the D degradable partition body 11 is connected with the second anti-infection liquid medicine sleeve 9 by medical adhesive, and the D degradable partition body 11 is connected with the inner partition pipe 5 by medical adhesive;
the anti-infection absorbable nursing urethral stent applicable to the hypospadias operation has the following functions;
A. after the tube body 1 is placed into the urethra of a patient, the bladder of the patient can be expanded and supported by means of the first balloon 2, the urethra of the patient can be expanded by the second balloon 3, and the degradable stent ring 4 is matched, so that the problem of stenosis after a hypospadias operation is effectively prevented;
B. because the degradable stent ring 4 is made of degradable biological material, the degradable stent ring can be dissolved in the urethra of a patient, good biocompatibility is realized, and the problem that the degradable stent ring 4 is not made of degradable material and is withdrawn together to bring great pain to the patient when the tube body 1 is dismantled in the traditional technology is solved;
C. in order to effectively avoid urethral infection, antibacterial and anti-inflammatory liquid medicines are injected into the first anti-infective liquid medicine sleeve 6 and the second anti-infective liquid medicine sleeve 9 in advance, and the degradable partition body A7, the degradable partition body B8, the degradable partition body C10 and the degradable partition body D11 are made of degradable biological materials, so that the degradable biological materials can be dissolved in the urethra of a patient, the antibacterial and anti-inflammatory liquid medicines in the first anti-infective liquid medicine sleeve 6 and the second anti-infective liquid medicine sleeve 9 can conveniently permeate into the urethra of the patient, the antibacterial and anti-inflammatory purposes are realized, and the problem of urethral infection of the patient is effectively avoided;
D. when the A degradable separation body 7, the B degradable separation body 8, the C degradable separation body 10 and the D degradable separation body 11 on the first anti-infection liquid medicine sleeve 6 and the second anti-infection liquid medicine sleeve 9 are dissolved, urine in the urethra is discharged from inside to outside, so that the urine can be conveniently contacted with the A degradable separation body 7, the B degradable separation body 8, the C degradable separation body 10 and the D degradable separation body 11 in sequence, and then the dissolution is ordered, so that the anti-bacterial and anti-inflammatory liquid medicines can conveniently permeate into the urethra of a patient in batches, the batch disinfection is realized, the anti-bacterial and anti-inflammatory time is prolonged, and external germs are effectively prevented from invading into the urethra of the patient in the catheterization process;
the front side and the rear side of the upper end inside the pipe body 1 and the inner partition pipe 5 are also provided with flow guide holes 101, and the flow guide holes 101 are through holes;
it should be noted that the flow guide holes 101 not only facilitate the urine to overflow, but also facilitate the medical staff to wash the urethra and bladder of the patient;
a first adjusting air pipe 201 is fixedly arranged at the middle end of the bottom of the first balloon 2, the first adjusting air pipe 201 is connected with the first balloon 2 through hot melting, a first adjusting valve 202 is fixedly arranged at the bottom of the first adjusting air pipe 201, the first adjusting valve 202 is connected with the first adjusting air pipe 201 through hot melting, a first connecting port 203 is fixedly arranged at the bottom of the first adjusting valve 202, and the first connecting port 203 is connected with the first adjusting valve 202 through hot melting;
it should be noted that the first regulating air pipe 201 can guide air flow, so that an external air supply device in the prior art can conveniently inflate and deflate the first balloon 2, the first regulating valve 202 can be rotated to be opened or closed, so that medical personnel can conveniently adjust the plugging state of the first regulating air pipe 201, and the first connecting port 203 can be butted with the air supply device in the prior art, so that subsequent inflation and deflation operations are convenient;
a second regulating air pipe 301 penetrates through the inner wall of the second balloon 3, the second regulating air pipe 301 and the second balloon 3 are in hot-melt connection, the second regulating air pipe 301 is in hot-melt connection with the pipe body 1 and the inner partition pipe 5 respectively, a second regulating valve 302 is fixedly arranged on the second regulating air pipe 301, the second regulating valve 302 and the second regulating air pipe 301 are in hot-melt connection, a second connecting port 303 is fixedly arranged at the bottom of the second regulating valve 302, and the second connecting port 303 and the second regulating valve 302 are in hot-melt connection;
it should be noted that the second regulating air tube 301 can guide air, so that an external air supply device in the prior art can conveniently inflate and deflate the second balloon 3, the second regulating valve 302 can be rotated to open or close, so that medical personnel can conveniently adjust the blocking state of the second regulating air tube 301, and the second connecting port 303 can be butted with the air supply device in the prior art, so that subsequent inflation and deflation operations are facilitated;
the outer wall of the degradable support ring 4 is fixedly provided with a plurality of anti-skid lugs 401 from top to bottom, and the protective lugs 401 and the degradable support ring 4 are integrally formed;
it should be noted that the anti-slip bumps 401 are distributed on the outer wall of the degradable stent ring 4, so that the anti-slip performance can be improved, the positioning of the degradable stent ring 4 can be realized, and the purpose of preventing the degradable stent ring 4 from slipping can be effectively achieved;
a first injection pipe 601 penetrates through the lower end inside the first anti-infective liquid medicine sleeve 6, the first injection pipe 601 is connected with the first anti-infective liquid medicine sleeve 6 through hot melting, the first injection pipe 601 is respectively connected with the degradable partition A7 and the degradable partition B8 through medical-grade adhesives, a first injection port 602 is fixedly arranged at the bottom of the first injection pipe 601, and the first injection port 602 is connected with the first injection pipe 601 through hot melting;
it should be noted that the first liquid injection pipe 601 can conveniently supply an external ascorbic acid liquid into the degradable partition A7 and the degradable partition B8, so as to accelerate the dissolution of the degradable partition A7 and the degradable partition B8, which is beneficial to the overflow of the antibacterial and anti-inflammatory liquid medicine inside the first anti-infective liquid medicine sleeve 6, namely, the urethra of the patient is conveniently subjected to antibacterial and anti-inflammatory treatment, and the first liquid injection port 602 can be connected with a liquid supply pipeline in the prior art, so as to conveniently supply the subsequent antibacterial and anti-inflammatory liquid medicine;
a second injection pipe 901 penetrates through the lower end inside the second anti-infection liquid medicine sleeve 9, the second injection pipe 901 is connected with the second anti-infection liquid medicine sleeve 9 in a hot melting mode, the second injection pipe 901 is connected with the C degradable partition 10 and the D degradable partition 11 respectively in a medical grade adhesive, a second injection port 902 is fixedly arranged at the bottom of the second injection pipe 901, and the second injection port 902 is connected with the second injection pipe 901 in a hot melting mode;
it should be noted that the second liquid injection tube 901 can conveniently supply an external ascorbic acid liquid to the C degradable spacer 10 and the D degradable spacer 11, so as to accelerate the dissolution of the C degradable spacer 10 and the D degradable spacer 11, which is beneficial to the overflow of the antibacterial and anti-inflammatory liquid inside the second anti-infection liquid medicine sleeve 9, i.e. to the antibacterial and anti-inflammatory treatment of the urethra of the patient, and the second liquid injection port 902 can be connected with a liquid supply pipe in the prior art, so as to facilitate the supply of the subsequent antibacterial and anti-inflammatory liquid medicine;
the degradable stent ring 4, the degradable partition body A7, the degradable partition body B8, the degradable partition body C10, the degradable partition body D11 and the anti-skid bump 401 are all made of biological materials which can be dissolved by ascorbic acid, and the biological materials which can be dissolved by the ascorbic acid are chitosan or similar biological materials;
it should be noted that, since the degradable stent ring 4, the degradable spacer A7, the degradable spacer B8, the degradable spacer C10, the degradable spacer D11 and the anti-skid block 401 are made of chitosan or similar biological materials which can be dissolved by ascorbic acid, when a patient urinates, the degradable stent ring 4, the degradable spacer A7, the degradable spacer B8, the degradable spacer C10, the degradable spacer D11 and the anti-skid block 401 can be slowly dissolved due to vitamin C with ascorbic acid in the urine, which is not only beneficial to absorption, but also convenient for subsequent antibacterial and anti-inflammatory treatment.
The above description is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, several modifications and variations can be made without departing from the technical principle of the present invention, and these modifications and variations should also be regarded as the protection scope of the present invention.
Claims (8)
1. An anti-infection absorbable nursing urethral stent applicable to after a hypospadias operation is characterized by comprising a tube body, a first balloon, a second balloon, a degradable stent ring, an inner spacer tube, a first anti-infection liquid medicine sleeve, an A degradable spacer body, a B degradable spacer body, a second anti-infection liquid medicine sleeve, a C degradable spacer body and a D degradable spacer body, wherein the first balloon is fixedly arranged at the top port of the tube body, the second balloon is fixedly arranged at the upper end of the outer wall of the tube body, the degradable stent frame is fixedly arranged at the outer wall of the second balloon, the inner spacer tube is arranged at the bottom of the tube body, the inner spacer tube is in hot-melt connection with the first balloon, the first anti-infection liquid medicine sleeve is fixedly arranged at the inner upper end of the tube body, the first anti-infection liquid medicine sleeve is in hot-melt connection with the inner spacer tube, the A spacer body is fixedly arranged at the inner upper end of the first anti-infection, the degradable partition body A is connected with the inner partition pipe through a medical adhesive, the degradable partition body B is fixedly arranged at the lower end inside the first anti-infection liquid medicine sleeve, the degradable partition body B is connected with the inner partition pipe through the medical adhesive, the second anti-infection liquid medicine sleeve is fixedly arranged at the lower end inside the pipe body, the second anti-infection liquid medicine sleeve is connected with the inner partition pipe through hot melting, the degradable partition body C is fixedly arranged at the upper end inside the second anti-infection liquid medicine sleeve, the degradable partition body C is connected with the inner partition pipe through the medical adhesive, the degradable partition body D is fixedly arranged at the lower end inside the second anti-infection liquid medicine sleeve, and the degradable partition body D is connected with the inner partition pipe through the medical adhesive.
2. The anti-infective absorbable nursing urethral stent suitable for use after a hypospadias operation as claimed in claim 1, wherein the tube body and the inner partition are provided with flow-guiding holes at the front and rear sides of the inner upper end thereof.
3. The anti-infective absorbable nursing urethral stent applicable to postoperative hypospadias as claimed in claim 1, wherein a first adjusting tube is further fixedly arranged at the middle end of the bottom of the first balloon, a first adjusting valve is further fixedly arranged at the bottom of the first adjusting tube, and a first connecting port is further fixedly arranged at the bottom of the first adjusting valve.
4. The anti-infective absorbable nursing urethral stent applicable to postoperative hypospadias as claimed in claim 1, wherein a second regulating air tube penetrates through the inner wall of the second balloon, the second regulating air tube is respectively connected with the tube body and the inner partition tube by hot melting, a second regulating valve is fixedly arranged on the second regulating air tube, and a second connecting port is fixedly arranged at the bottom of the second regulating valve.
5. The anti-infective absorbable urethral stent suitable for use after a hypospadias procedure in claim 1, wherein the outer wall of the degradable stent ring is further provided with a plurality of anti-skid projections from top to bottom.
6. The anti-infective absorbable nursing urethral stent applicable to postoperative hypospadias as claimed in claim 1, wherein a first injection tube further penetrates through the lower end of the interior of the first anti-infective liquid medicine sleeve, the first injection tube is respectively connected with the degradable partition A and the degradable partition B by medical-grade adhesive, and a first injection port is further fixedly arranged at the bottom of the first injection tube.
7. The anti-infective absorbable nursing urethral stent applicable to postoperative hypospadias as claimed in claim 1, wherein a second infusion tube penetrates through the lower end of the interior of the second anti-infective drug solution sleeve, the second infusion tube is connected with the degradable spacer C and the degradable spacer D by medical grade adhesive, and a second infusion port is fixedly arranged at the bottom of the second infusion tube.
8. The anti-infective absorbable nursing urethral stent suitable for use after a hypospadias operation in claim 1, wherein the degradable stent ring, the degradable barrier A, the degradable barrier B, the degradable barrier C, the degradable barrier D and the anti-slip bump are all made of biological materials which can be dissolved by ascorbic acid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110081373.6A CN112914799A (en) | 2021-01-21 | 2021-01-21 | Anti-infection absorbable nursing urethral stent suitable for hypospadias operation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110081373.6A CN112914799A (en) | 2021-01-21 | 2021-01-21 | Anti-infection absorbable nursing urethral stent suitable for hypospadias operation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112914799A true CN112914799A (en) | 2021-06-08 |
Family
ID=76163974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110081373.6A Pending CN112914799A (en) | 2021-01-21 | 2021-01-21 | Anti-infection absorbable nursing urethral stent suitable for hypospadias operation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112914799A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107427612A (en) * | 2014-10-07 | 2017-12-01 | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | Degradable medical treatment device on demand |
| CN109893682A (en) * | 2019-04-16 | 2019-06-18 | 东北大学 | A kind of degradable metal ureter bracket and preparation method with composite construction |
| CN209033485U (en) * | 2018-01-04 | 2019-06-28 | 张耀文 | A kind of antimicrobial form catheter and urethral catheterization device |
| CN209575493U (en) * | 2018-12-20 | 2019-11-05 | 代庆志 | A kind of film envelope drug storage degradable medical conduit |
| CN111096831A (en) * | 2020-01-19 | 2020-05-05 | 南京市儿童医院 | Anti-infection absorbable urethral stent used after hypospadias operation |
-
2021
- 2021-01-21 CN CN202110081373.6A patent/CN112914799A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107427612A (en) * | 2014-10-07 | 2017-12-01 | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | Degradable medical treatment device on demand |
| CN209033485U (en) * | 2018-01-04 | 2019-06-28 | 张耀文 | A kind of antimicrobial form catheter and urethral catheterization device |
| CN209575493U (en) * | 2018-12-20 | 2019-11-05 | 代庆志 | A kind of film envelope drug storage degradable medical conduit |
| CN109893682A (en) * | 2019-04-16 | 2019-06-18 | 东北大学 | A kind of degradable metal ureter bracket and preparation method with composite construction |
| CN111096831A (en) * | 2020-01-19 | 2020-05-05 | 南京市儿童医院 | Anti-infection absorbable urethral stent used after hypospadias operation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20070288051A1 (en) | Fluid-filled cervical dilator | |
| KR20100025511A (en) | Catheter | |
| CN103111010A (en) | Double-cavity sacculus tube and application thereof | |
| CN102389346B (en) | Bladder stoma without urine collecting bag | |
| CN107376100A (en) | Infant anus rectum supporting drainage pipe | |
| CN108969868B (en) | Catheter with expansion bag | |
| CN112190824A (en) | Multifunctional double-balloon catheter | |
| CN112914799A (en) | Anti-infection absorbable nursing urethral stent suitable for hypospadias operation | |
| CN108066884A (en) | Ureteral catheter and its application method with sacculus | |
| CN208926788U (en) | Three chambers, the two capsule Lacrimal passage tube for obstruction of lacrimal passage of adjustable expansion | |
| CN107233655B (en) | Use method of ureter double-balloon drainage tube and double-balloon drainage tube structure thereof | |
| WO2010041084A1 (en) | Medical device | |
| CN213347384U (en) | Indwelling double-balloon cricopharyngeal muscle dilating device | |
| CN210873651U (en) | Urethra support tube used after hypospadias | |
| CN103463727A (en) | Four-chamber double-balloon urinary catheter | |
| CN210542827U (en) | Anti-retrograde infection indwelling catheter | |
| CN209019721U (en) | Catheter with swelling bag | |
| CN202777405U (en) | Prostate post operation drug injection type catheter | |
| CN111420240A (en) | Urethral dilatation bougie drainage tube with step-by-step dilatation saccule | |
| CN206081288U (en) | Comfortable ureter | |
| CN213911922U (en) | Multifunctional double-balloon catheter | |
| CN213667454U (en) | Urethral catheterization device convenient to wash and capable of preventing wound infection after hypospadias | |
| CN203090035U (en) | Combined flushing device for bladder and urethra | |
| KR102408167B1 (en) | Foley catheter assembly | |
| CN217286853U (en) | Sinus ostium dilation balloon assembly |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |